LNSR - NASDAQ

LENSAR, Inc.

LNSR·NASDAQ

$5.57

-4.9%

HealthcareMedical - Devices

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$67.42M

EPS-2.8700

P/E Ratio-1.94

Earnings Date08/06/2026

lnsr

Total Non-Current Liabilities

Last Annual Value

56.88M

3-Year CAGR

186%

5-Year CAGR

75%

10-Year CAGR

Adjust for Inflation

LENSAR, Inc. Competitors Analysis of Total Non-Current Liabilities

LNSR · NASDAQ

Company	Total Non-Current Liabilities	CAGR 3Y	CAGR 5Y	CAGR 10Y
LENSAR, Inc. NASDAQ:LNSR	56.88M	74.1%	81.7%	N/A
Cardiff Oncology, Inc. NASDAQ:CRDF	102.00K	-58.8%	-47.5%	-39.8%
TriSalus Life Sciences, Inc. NASDAQ:TLSI	57.69M	16.0%	152.6%	N/A
Sight Sciences, Inc. NASDAQ:SGHT	40.33M	5.7%	3.1%	N/A
Apyx Medical Corporation NASDAQ:APYX	40.31M	0.6%	93.0%	27.3%
Hyperfine, Inc. NASDAQ:HYPR	2.52M	34.7%	37.7%	N/A
Lucid Diagnostics Inc. NASDAQ:LUCD	927.00K	67.0%	N/A	N/A
AVITA Medical, Inc. NASDAQ:RCEL	10.37M	-40.6%	35.8%	N/A
Spero Therapeutics, Inc. NASDAQ:SPRO	1.03M	-70.1%	-56.2%	7.6%
Rapid Micro Biosystems, Inc. NASDAQ:RPID	23.16M	52.9%	62.8%	N/A
Owlet, Inc. NYSE:OWLT	5.93M	-40.9%	-17.8%	N/A

LENSAR, Inc. Fair Value Envelope

LNSR · NASDAQ

Our analysis suggests that LNSR has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $5.57, this represents a potential HIDDEN relative to our calculated worth for LENSAR, Inc..

HIDDEN

Intrinsic Value

Current Price: $5.57

Related Guides

Blog Categories

Continue your LNSR research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.